Article Listing - Genzyme's Myozyme begins Pompe study

CHOLINE KEY TO ALZHEIMER'S?

9 March 1992

New research has indicated that a deficiency of the acetylcholine precursor choline may be a prime factor in the etiology...

RETROVIR AND AIDS PATIENT SURVIVAL

9 March 1992

Backing that Wellcome's antiretroviral product Retrovir (zidovudine) improves the survival of patients with AIDS has come from a study by...

ANTI-LEPTOSPIRA MAbs FROM BRAZIL

9 March 1992

Researchers at the Oswaldo Cruz Foundation in Rio de Janeiro, Brazil, claim to have produced monoclonal antibodies specific for blood-borne...

FDA PLANS MOVES ON DRUG ADS

9 March 1992

The US Food and Drug Administra-tion has recently issued 10-15 letters on violative reminder ads for prescription drugs and is...

CHANGING FACE OF THE ASTHMA MARKET

9 March 1992

While some analysts have voiced belief that Glaxo may have a tough time getting its long-acting bronchodilator Serevent (salmeterol xinafoate)...

FDA FRAUD POLICY EXPLAINED

9 March 1992

Application by the US Food and Drug Administration of its fraud policy against companies suspected of wrongdoing would not slow...

US GAO SLAMS FDA REVIEW OF OTCs

9 March 1992

There is less US Food and Drug Administration scrutiny of over-the-counter drug products than of prescription products, says a new...

LITHIUM AND PREGNANCY

9 March 1992

Results of a prospective multicenter study of pregnancy outcome after lithium exposure during the first trimester suggest that it is...

PRODUCT UPDATE FROM INTERNEURON PHARMA

9 March 1992

Massachusetts company Interneuron Pharma has signed an agreement with Purdue University to license exclusive worldwide rights to its putative antiparkinsonism...

BAYER AG'S JONATHAN TALBUTT

9 March 1992

Jonathan Talbutt is appointed international product manager, diabetes, at Bayer AG, based in Leverkusen, Germany.

Showing 94711-94720 of 95325 articles